BIIB's Track Record: Perfect Beat Rate, Flat Post-Drift
Across the last eight reported quarters, Biogen (BIIB) has beaten the consensus estimate in all eight, a 100% beat rate, with an average earnings surprise of 18.2%. That headline consistency might suggest a strongly positive post-earnings drift, yet the average five-trading-day move after those reports is just 0.09%, directionally classified as flat. The recent results make that disconnect concrete. On April 29, 2026, BIIB reported actual EPS of $3.57 against an estimate of $3.05, a 17.0% beat, but the stock fell 2.62% the next session and 1.9% over the following five days. On February 6, 2026, EPS came in at $1.99 versus $1.63, a 22.1% surprise, yet the stock dropped 3.66% the next day and 2.32% over the next five days. Only the October 30, 2025 report—actual EPS $4.81 versus $3.88, a 24.0% beat—produced a follow-through: +3.11% the next day and +4.77% over five sessions. Even the largest recent surprise, July 31, 2025—actual EPS $5.47 versus $3.90, a 40.3% beat—gained just 3.09% the next day and then gave back nearly everything, finishing the next five trading days down 0.2%. For BIIB, a beat has not reliably translated into a sustained price gain.
How Options Markets Are Pricing the July 29 Report
BIIB is scheduled to report next on July 29, 2026 before the open, with a consensus EPS estimate of $3.13. The stock closed at $205.99, above its 50-day EMA of $198.89, with RSI at 52.8. Because the company has beaten expectations in 8 of the last 8 quarters, option-implied volatility can rise into the print as traders position for a move. Market makers may widen straddle prices to reflect that history, especially if the unofficial consensus—different from the published $3.13 estimate—suggests the real bar is higher. After the release, implied volatility typically compresses, so the post-earnings price must move more than the option market anticipated for long-gamma positions to pay out. With the average five-day post-earnings drift at only 0.09%, the gap between expected volatility and realized volatility has been a recurring feature of BIIB earnings weeks.
What a Disciplined Trader Watches on July 29
The pattern to monitor is not whether BIIB beats, but how the market responds after it does. A disciplined trader would mark the $198.89 fifty-day EMA as a nearby reference and note that RSI at 52.8 is neutral, giving neither an oversold bounce setup nor a crowded long condition. The relevant comparison is the opening gap versus the prior four outcomes. If the stock gaps higher on July 29, the precedent from October 30, 2025 is an exception, not the rule: three of the last four reports saw a five-day drift that was negative or flat after a next-day move. Volume, option flow asymmetry, and whether implied volatility collapses faster than the stock can move all matter more than the surprise percentage itself. Traders should also track whether the market's real expectation embeds a higher EPS bar than the $3.13 consensus, because a reported beat against the published number can still feel like a miss if positioning had priced in stronger results.
For a deeper dive into how analysts, institutions, and alternative data currently rate BIIB heading into the July 29 report, explore the full institutional verdict on the platform.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-04-29 | $3.57 | $3.05 | +17% | -2.62% | -1.9% |
| 2026-02-06 | $1.99 | $1.63 | +22.1% | -3.66% | -2.32% |
| 2025-10-30 | $4.81 | $3.88 | +24% | +3.11% | +4.77% |
| 2025-07-31 | $5.47 | $3.9 | +40.3% | +3.09% | -0.2% |
| 2025-05-01 | $3.02 | $2.9 | +4.1% | - | - |
| 2025-02-12 | $3.44 | $3.43 | +0.3% | - | - |
Get the institutional verdict on BIIB
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the BIIB verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.